Stock comparison
JOHNSON & JOHNSON is 19.4x more valuable than BeOne Medicines AG by market capitalization ($622.64 B vs $32.14 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 19.4x more valuable than BeOne Medicines AG by market capitalization ($622.64 B vs $32.14 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 19.4x more valuable than BeOne Medicines AG by market capitalization ($622.64 B vs $32.14 B).
Revenue leader
JNJ
ONC: $5.34B vs JNJ: $94.19B.
Profit leader
JNJ
ONC: $286.93M vs JNJ: $26.80B.
Margin leader
JNJ
ONC: 5.4% vs JNJ: 28.5% net margin.
| Metric | ONC | JNJ |
|---|---|---|
| Market cap | $32.14 B | $622.64 B |
| US-listed rank | #446 | #18 |
| Revenue (latest FY) | $5.34B | $94.19B |
| Net income (latest FY) | $286.93M | $26.80B |
| Net margin | 5.4% | 28.5% |
| P/E (trailing FY) | 112.0x | 23.2x |
| SEC filings | 1,165 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 19.4x more valuable than BeOne Medicines AG by market capitalization ($622.64 B vs $32.14 B).
In their latest fiscal years, BeOne Medicines AG reported $5.34B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: BeOne Medicines AG and JOHNSON & JOHNSON, or browse the full rankings.